Figure 2 The effects of a Jak 1/2 inhibitor on chronic active EBV infection (CAEBV). (IMAGE)

Tokyo Medical and Dental University

Figure 2 The effects of a Jak 1/2 inhibitor on chronic active EBV infection (CAEBV).

Caption

A Jak1/2 inhibitor ruxolitinib suppressed the number of viable CAEBV patients' cells (A). Ruxolitinib also suppressed the production of interferon-γ in CAEBV patients' cells (B).

Credit

Department of Laboratory Molecular Genetics of Hematology,TMDU

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.